SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global I.V. dressing market is estimated to be valued at US$ 724.2 million in 2021 and is expected to exhibit a CAGR of 5.7% over the forecast period (2021-2028).
Key Trends and Analysis of the Global I.V. Dressing Market:
I.V. dressings are frequently used during chemotherapies, thus increasing prevalence of cancer is expected to create lucrative opportunity in the global I.V. dressing market over the forecast period. For instance, according to the American Cancer Society, in 2019, there was an estimated 1,762,450 newly diagnosed cancer cases and 606,880 cancer deaths in the U.S. Furthermore, according to the International Agency for Research on Cancer (IARC), the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018.
Furthermore, patients suffering from swallowing disorders such as dysphagia occurring due to Alzheimer's disease, Parkinson's disease, and other diseases require intravenous (IV) fluids. Hence, increasing incidence of dysphagia is expected to drive the IV dressing market growth over the forecast period. For instance, according to an article published in the ScienceDirect platform in July 2018, dysphagia was found in around 56.9% chronic stroke patients, 46.2% in Parkinson's disease patients, 40.8% in Alzheimer's disease patients, 50.0% in Amyotrophic Lateral Sclerosis patients, and around 35.5% in people suffering from head/neck cancer in China.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/3182
Moreover, the increasing number of catheterization procedure is also expected to offer significant opportunities in the I.V. dressing market in the near future. For instance, according to the data published in National Center for Biotechnology Information in July 2020, more than 1,000,000 cardiac catheterization procedures are performed annually in the U.S.
Key Market Takeaways:
The global I.V. dressing market is expected to exhibit a CAGR of 5.7% over the forecast period, increasing hospitalizations due to gastrointestinal, liver, and pancreatic diseases. According to an article published in the Gastroenterology journal in 2019, the number of hospitalizations due to gastrointestinal, liver, and pancreatic diseases in the U.S. in 2014 are as given in the table below:
Competitive Landscape:
Key players operating in the global I.V. dressing market include Becton, Dickinson and Company, Lohmann & Rauscher, Komal Health Care Pvt. Ltd., Paul Hartmann AG, DeRoyal Industries Inc., Tytex, Shandong Dermcosy Medical Co., Ltd., Smith & Nephew plc, Dynarex Corporation, Talent Healthcare, 3M, and Datt Mediproducts Pvt. Limited.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3182
Market Segmentation:
- Global I.V. Dressing Market , By Product Type:
- Transparent
- Translucent
- Global I.V. Dressing Market , By End User:
- Hospital
- Clinics
- Others
- Global I.V. Dressing Market , By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- By Country
- North America
Related Market Intelligence Reports:
Interventional Oncology Ablation Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Irreversible Electroporation Ablation), by Indication (Liver Cancer, Kidney Cancer, Lung Cancer, and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2027
Read more: https://www.coherentmarketinsights.com/market-insight/interventional-oncology-ablation-market-4445
China Orthosis and Prosthetics Market, by Product Type (Orthosis (Knee Ankle Foot Orthoses (KAFO), Wrist Hand Orthoses (WHO), Foot Orthoses (FO), Ankle Foot Orthoses (AFO), Elbow Orthosis (EO), Hip Knee Ankle Foot Orthoses (HKAFO), Shoulder Orthoses, Upper Limb Orthoses, and Others), and Prosthetic (Below Knee (BK) – Transtibial, Above Knee (AK) – Transfemoral, and Upper Extremity (UE) - Transradial, Transhumeral), by Age Group (Pediatric and Adult), and by Indication (Lower Limb Deformities, Upper Limb Deformities, and Others (Spinal) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Read more: https://www.coherentmarketinsights.com/market-insight/china-orthosis-and-prosthetics-market-4443
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.